In a survey of 1,904 people, 39% of users reported nail detachment, against 9% of non-users. The authors say the design can't show the drugs caused it.
Recap by typeshit. Full story at ScienceAlert.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
One paper found over 20% of patients had a deficiency after a year. A U of T pharmacist says many people now get a prescription with no follow-up support.
FDA labels for Mounjaro and Zepbound say about 20% less contraceptive hormone was absorbed after a single dose. Reproductive endocrinologists explain what that means for birth control.
Loading…